DIALYSIS SOLUTIONS INC.

Slides:



Advertisements
Similar presentations
Regional Citrate Anticoagulation during CVVH in the
Advertisements

Norma J Maxvold Pediatric Critical Care
Renal Replacement Therapy Options for Children
Definition Continuous Renal Replacement Therapy (CRRT)
So how do I dose this drug “X” Timothy E Bunchman
Elsevier items and derived items © 2007, 2003, 2000 by Saunders, an imprint of Elsevier Inc. Slide 1 Chapter 25 Water, Electrolyte, and Acid-Base Balance.
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
CRRT solutions Benan Bayrakci, 2014.
Fluid and Electrolyte Therapy. Introduction: The molecules of chemical compounds in solution may remain intact, or they may dissociate into particles.
In human physiology, base excess and base deficit refer to an excess or deficit, respectively, in the amount of base present in.
Pediatric CRRT: Dialysis and Replacement Solutions William E. Smoyer, M.D. Pediatric Nephrology University of Michigan.
Dialysis and Replacement Solutions for CRRT
Dr Umut Selda Bayrakçı Yıldırım Beyazıt University, Dept of Pediatric Nephrology, Ankara, Turkey * Basics of CRRT Terminology.
Intensive care conference: management of acid-base disorders with CRRT International Society of Nephrology 主講人 : R2 顏介立.
Troubleshooting Issues in CVVH Timothy L. Kudelka RN, BSN Pediatric Dialysis Program C.S. Mott Children’s Hospital University of Michigan.
Distribution of Body Solids & Fluids Fluid Exchange Processes in our body: Filtration Reabsorption Diffusion Osmosis.
Pediatric CRRT The Prescription: Rates, Dose, Fluids
Terminology and Common Issues in Pediatric CRRT John Gardner RN, BSN Nurse Manager Pediatric Nephrology & Transplant DeVos Children’s Hospital Grand Rapids.
Dialysis and Replacement Solutions for Pediatric CRRT
ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital.
What form of anticoagulation is the “best” Or why is Citrate better then Heparin or Prostacyclin.
Body fluids Electrolytes. Electrolytes form IONS when in H2O (ions are electrically charged particles) (Non electrolytes are substances which do not split.
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
PCRRT PRESCRIPTIONS in ARF Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
ANTICOAGULATION in CRRT: Heparin vs. Citrate
Tomáš Zaoral1, Michal Hladík1, Jana Zapletalová2 1Pediatric intensive care unit, Department of Pediatrics,Faculty of Medicine, University Hospital Ostrava.
Acid-Base Imbalances. pH< 7.35 acidosis pH > 7.45 alkalosis The body response to acid-base imbalance is called compensation If underlying problem is metabolic,
Fluid Therapy 24 April, 2009 review. Ⅰ Ⅰ fluid balance in child 1. The total amount of body fluids in children : The younger, The younger, the greater.
Sustained Low Efficiency Dialysis
Brophy University of Iowa Pediatric CRRT Anticoagulation Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital PCRRT.
Citrate Anticoagulation
Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.
REACTIVE OR PROACTIVE: WHICH IS BEST IN RENAL REPLACEMENT THERAPY PHOSPHATE CONTROL? Joanna Campion-Smith Gurudutta Venkatesha Molly McLaughlin Meeta Mallik.
Quen Mok Great Ormond Street Hospital. Chloride: Queen of electrolytes?
ANTICOAGULATION PCRRT 2008 Orlando Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital.
Carl P. Walther*, Amber S. Podoll*, Kevin W. Finkel* *The University of Texas Health Science Center at Houston Citrate Toxicity During CRRT After Massive.
PCRRT Multi-Center Registry Data Effective April 1, 2002 Multi-Center Pediatric CRRT Registry Stuart L. Goldstein, MD Assistant Professor of Pediatrics.
Percents and Solutions
Dosing of Anti-Fungal agents on CRRT Timothy E. Bunchman Professor and Director Pediatric Nephrology & Transplantation Children’s Hospital of Richmond.
PCRRT Tûr'mə-nŏl'ə-jē Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Citrate Continuous Renal Replacement Therapy: Which Protocol? Standard Protocol 1 (SP1) Indication: First hours of therapy Effluent dose target:
Original slide prepared for the IGCSE Electron arrangement in Atoms and Ions.
CONTINUOUS RENAL REPLACEMENT THERAPY
CRRT Fundamentals Pre- and Post- Test
Clinical Review Process for New Drug Development and Application
Ghazanfar Abbas Medical technologist (SIUT)
Anatomy & Physiology I Unit Three.
Including: Anticoagulation Prescribing Protocol
Improving outcomes in AKI and CRRT: Does Quality matter?
Devices use for Neonatal AKI
Prescriptions in CRRT Timothy E Bunchman MD Professor & Director
Vascular Access and Infused Fluids for Pediatric CRRT
Practical Considerations for CRRT
Fluid and Electrolyte Therapy
OUTCOMES OF REGIONAL CITRATE ANTICOAGULATION (RCA) IN PEDIARTIC CONTINUOUS RENAL REPLACEMENT THERAPY (pCRRT) IN A SINGLE CENTER Issa Alhamoud, Diane Gollhofer,
Buffer transport in peritoneal dialysis
Electrolyte Solutions: Milliequivalents, Millimoles, and Milliosmoles
Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration  Gerd R. Hetzel, MD, Gediz Taskaya, Christoph.
Pediatric CRRT Terminology
Fluid and Electrolyte Therapy
Children’s Memorial Hospital Northwestern University
Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.
CRRT dialysis circuit using regional citrate anticoagulation with the Gambro Prisma machine. CRRT dialysis circuit using regional citrate anticoagulation.
Cardiac arrest and sudden death in dialysis units
The role of daily dialysis in the control of hyperphosphatemia
Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction  Adam G. McLean, Andrew Davenport, Dominic.
Role of sodium in hemodialysis
Gregory Proctor, MD, Stuart Linas, MD 
Carbon dioxide transport in blood.
Presentation transcript:

DIALYSIS SOLUTIONS INC. PCRRT Conference Orlando, FL June 20th, 2008

CVVH: Bicarbonate vs Lactate Barenbrock M et al, Kid Int 58:1951-1957, 2000 P value Plasma Bicarbonate (mmol/l) 23.7 + 0.4 21.8 + 0.5 < 0.01 Blood Lactate (mg/dl) 17.4 + 8.5 28.7 + 10.4 < 0.05 IV Bicarb given over 24 hrs 13 + 7 68 + 39

CVVH: Bicarb vs Lactate Barenbrock M et al, Kid Int 58:1951-1957, 2000 Dark bar = Bicarb Light bar = lactate

Normocarb HF CRRT SHOULD FIX METABOLIC DISTURBANCES, NOT CAUSE THEM. Normocarb is the right formulation to provide key electrolytes in the physiologically correct concentrations with no unnecessary components and maximum flexibility.

DSI Milestones 1999 – Original Patent for NC35 applied for 2001 July – Walter O’Rourke joins as consultant 2001 December – Normocarb receives FDA 510K approval as device 2002 January – DSI records first US sales of Normocarb 2002 June – Pediatric Nephrology: Pediatric Hemofiltration: Normocarb Dialysate Solution with Citrate Anticoagulation; Bunchman 2002 June – BBraun agreement signed 2002 July – Normocarb receives Canadian DIN 2003 June – Journal of Critical Care: A Novel Regional Citrate Anticoagulation Protocol for CRRT Using Only Commercially Available Solutions; Tobe

DSI Milestones 2003 December – AJKD: Pediatric Convective Hemofiltration: Normocarb Replacement and Citrate Anticoagulation; Bunchman 2005 August – FDA grants Orphan Drug Status to the CRRT indication based on DSI’s application 2006 January – FDA 510K Approval for NC25 2006 May – Canadian Patent issued on NC25 2006 July – DSI receives an NDA for NC25HF/NC35HF 2006 November – DSI launches HF Products 2007 August – DSI receives US patent for 25 bicarb products

Therapy Evolution Diffusion based dialysis requiring device or combination product approved solutions Citrate Hemofiltration dialysis requiring drug approved solutions Volume

Solution Evolution Lactate Buffered – PD Solutions – Dialysate Pharmacy Made – Calcium Containing – Bicarbonate Solutions – Dialysate Citrate Pharmacy Made – Calcium Free – Bicarbonate Solutions – Dialysate Add Mixture Pharmacy Solutions – Calcium Free – Bicarbonate – Dialysate Normocarb – Calcium Free – Dialysate Normocarb NDA as hemofiltration solution for direct infusion

Dialysate vs. Hemofiltration Solution Normocarb HF Dialysate vs. Hemofiltration Solution

Normocarb 35 HF NC 35 HF mEq/L Sodium (Na) 140 Magnesium (Mg) 1.5 Chloride (Cl) 106.5 Bicarbonate (HCO3) 35 Potassium (K) 0 Calcium (Ca) 0

Normocarb 25 HF NC 25 HF mEq/L Sodium (Na) 140 Magnesium (Mg) 1.5 Chloride (Cl) 116.5 Bicarbonate (HCO3) 25 Potassium (K) 0 Calcium (Ca) 0

Normocarb HF Simple Preparation Maximum Flexibility Potassium can be added. Calcium can be added Dextrose can be added